Literature DB >> 2051954

Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism.

L T Baxter1, R K Jain.   

Abstract

We have previously developed a general theoretical framework for transvascular exchange and extravascular transport of fluid and macromolecules in tumors. The model was first applied to a homogeneous, alymphatic tumor, with no extravascular binding (Baxter and Jain, 1989). For nonbinding molecules the interstitial pressure was found to be a major contributing factor to the heterogeneous distribution of macromolecules within solid tumors. A steep pressure gradient was predicted at the periphery of the tumor, and verified in recent experiments. The second paper in this series looked at the role of heterogeneous perfusion and lymphatics on the interstitial pressure distribution and concentration profiles of non-binding macromolecules (Baxter and Jain, 1990). The present work presents the role of specific binding and metabolism in macromolecular uptake and distribution. In this investigation the interstitial concentration profiles for IgG and its fragment, Fab, were modeled with a convective-diffusion equation which includes extravascular binding and metabolism as well as transvascular exchange. The effects of molecular weight, binding affinity, antigen density, initial dose, plasma clearance, vascular permeability, metabolism, and necrosis were considered. An expression for optimal affinity was derived. The main conclusion is that an antibody with the highest possible binding affinity should be used except when: (i) there are significant necrotic regions; (ii) the diffusive vascular permeability is very small; and (iii) a uniform concentration is required on a microscopic scale. The highest concentrations are achieved by continuous infusion, but the specificity ratio is highest for bolus injections. Antibody metabolism reduces both the total concentration and the specificity ratio, especially at later times. In addition, specific binding reduces the amount of material sequestered in a necrotic core. Our model is compared with three previous models for antibody binding found in the literature. Unlike previous models, this model combines nonuniform filtration, binding, and interstitial transport to determine macroscopic concentration profiles. In addition to supporting previous conclusions, our model offers some new strategies for therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051954     DOI: 10.1016/0026-2862(91)90003-t

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  56 in total

1.  Simulation of the delivery of doxorubicin to hepatoma.

Authors:  Y M Goh; H L Kong; C H Wang
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

2.  Measurement of mass transport and reaction parameters in bulk solution using photobleaching. Reaction limited binding regime.

Authors:  E N Kaufman; R K Jain
Journal:  Biophys J       Date:  1991-09       Impact factor: 4.033

3.  Mathematical Modelling of Convection Enhanced Delivery of Carmustine and Paclitaxel for Brain Tumour Therapy.

Authors:  Wenbo Zhan; Davis Yohanes Arifin; Timothy Ky Lee; Chi-Hwa Wang
Journal:  Pharm Res       Date:  2017-02-02       Impact factor: 4.200

Review 4.  Distribution of drugs following controlled delivery to the brain interstitium.

Authors:  M Mak; L Fung; J F Strasser; W M Saltzman
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

5.  The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors.

Authors:  Lei Miao; Jay M Newby; C Michael Lin; Lu Zhang; Feifei Xu; William Y Kim; M Gregory Forest; Samuel K Lai; Matthew I Milowsky; Sara E Wobker; Leaf Huang
Journal:  ACS Nano       Date:  2016-09-28       Impact factor: 15.881

Review 6.  1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors.

Authors:  R K Jain
Journal:  Ann Biomed Eng       Date:  1996 Jul-Aug       Impact factor: 3.934

7.  A tumor cord model for doxorubicin delivery and dose optimization in solid tumors.

Authors:  Steffen Eikenberry
Journal:  Theor Biol Med Model       Date:  2009-08-09       Impact factor: 2.432

8.  Multiscale tumor spatiokinetic model for intraperitoneal therapy.

Authors:  Jessie L-S Au; Peng Guo; Yue Gao; Ze Lu; Michael G Wientjes; Max Tsai; M Guillaume Wientjes
Journal:  AAPS J       Date:  2014-02-26       Impact factor: 4.009

Review 9.  Vascular and interstitial barriers to delivery of therapeutic agents in tumors.

Authors:  R K Jain
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

10.  Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.

Authors:  F J Burrows; P E Thorpe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.